Ever since we started our coverage of FD products at PrimeInvestor, we’ve taken a very conservative approach to the entities whose deposits we recommend. Always putting capital safety over rates, our recommended list of FDs has been made up mainly of post office schemes, systemically important banks and very select NBFCs.
Recent reports suggest that as many as 35% of health insurance buyers in recent times – mainly in their 30s and 40s – are buying Rs 1 crore health insurance plans, against just 5% who used to buy them earlier.
Home loans are one of the safer lending avenues for NBFCs, given that they are backed by collateral that usually appreciates in price. But does that make bond offers from two housing finance NBFCs – Piramal Capital and Housing Finance and IIFL Housing – less risky to bet on? Here’s our analysis.
Have you ever wondered why health insurers in India keep their claims data a closely guarded secret, while life insurers advertise it? Life insurers prominently display their claims settlement ratios of 98% or 99%, but health insurance pitches are full of emotional testimonials on how ‘timely’ payouts saved the life of a near-and-dear one.
With the bull market in full swing, there’s no dearth of investors, trading platforms and fintech firms out to convince you that making money from equities is a breeze.
Ads for a fintech firm show folks who can’t manage everyday stuff like shopping, exercising or keeping to a diet, trading in stocks as easy as pie.
Newly sprung up investing gurus tell you that all you need to do to earn untold riches, is to identify a bunch of ‘quality’ stocks and invest in them robotically.
Today, many personal finance articles tell you that one of the biggest personal finance take-aways from Covid is that everyone ought to sign up for a generous health insurance cover. But they fail to include the statutory warning that must come with every such plug – “Don’t expect your hospital bills to be settled in full”.
Prompted by real-life experiences of many investors who had filed claims for Covid treatment, PrimeInvestor conducted a Twitter dipstick survey in the last week of May on the claims settlement experience of policyholders.
Many investors are attracted to Real Estate Investment Trusts (REITs) because they seem to offer best of both the worlds – regular income payouts like bonds and the prospect of capital appreciation like equities. But what about REIT Taxation?
This is Part II of our series on REITs. You can find the first part here. Apart from a secret passion for owning real estate,
The onset of the second wave of Covid has put long-term debt investors in India in a Trishanku-like situation (Trishanku was a king in Hindu
IndiaGrid Invit is making a Rs 1,000 crore public issue of secured redeemable Non-Convertible Debentures (NCDs) from April 28 2021 to April 30 2021 to
If there’s one thing that governments love to do with their annual Budgets, it is to confuse ordinary folk with rule changes that have plenty of the fine print. This time, the change that has set off a confusing debate has been the budget proposal to limit the tax breaks on the Employees Provident Fund (EPF), the favourite retirement savings vehicle for many salary-earners. So, what changed for EPF subscribers in the 2021 Budget? Has the government now relaxed those provisions in the Finance Bill? What is the government trying to do to the EPF overall and should you be looking at alternatives to it? We answer these questions and many more here.
Kalyan Jewellers’ IPO is upon us and Aarati is here with the most detailed analysis and opinion piece on the offering – Should you buy or not? Either way, read this article first!
Legal Disclaimer : PrimeInvestor Financial Research Pvt Ltd (with brand name PrimeInvestor) is an independent research entity offering research services on personal finance products to customers. We are a SEBI registered Research Analyst (Registration: INH200008653). The content and reports generated by the entity does not constitute or is not intended to constitute an offer to buy or sell, or a solicitation to an offer to buy or sell financial products, units or securities. All content and information are provided on an ‘as is’ basis by PrimeInvestor Financial Research Pvt Ltd. Information herein is believed to be reliable but PrimeInvestor Financial Research Pvt Ltd does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. The services rendered by PrimeInvestor Financial Research Pvt Ltd are on a best-effort basis. PrimeInvestor Financial Research Pvt Ltd does not assure or guarantee the user any minimum or fixed returns. PrimeInvestor Financial Research Pvt Ltd or any of its officers, directors, partners, employees, agents, subsidiaries, affiliates or business associates will not liable for any losses, cost of damage incurred consequent upon relying on investment information, research opinions or advice or any other material/information whatsoever on the web site, reports, mails or notifications issued by PrimeInvestor Financial Research Pvt Ltd or any other agency appointed/authorised by PrimeInvestor Financial Research Pvt Ltd. Use of the above-said information is at the user’s own risk. The user must make his own investment decisions based on his specific investment objective and financial position and using such independent advisors as he believes necessary. All intellectual property rights emerging from this website, blog, and investment solutions are and shall remain with PrimeInvestor Financial Research Pvt Ltd. All material made available is meant for the user’s personal use and such user shall not resell, copy, or redistribute the newsletter or any part of it, or use it for any commercial purpose. PrimeInvestor Financial Research Pvt Ltd, or any of its officers, directors, employees, or subsidiaries have not received any compensation/ benefits whether monetary or in kind, from the AMC, company, government, bank or any other product manufacturer or third party, whose products are the subject of its research or investment information. The performance data quoted represents past performance and does not guarantee future results. Investing in financial products involves risk. Investments are subject to market risk. Please read all related documents carefully. As a condition to accessing the content and website of PrimeInvestor Financial Research Pvt Ltd, you agree to our Terms and Conditions of Use, available here. This service is not directed for access or use by anyone in a country, especially the USA, Canada or the European Union countries, where such use or access is unlawful or which may subject PrimeInvestor Financial Research Pvt Ltd or its affiliates to any registration or licensing requirement.
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Compliance Officer Details: Name: Srikanth Meenakshi; Email: contact@primeinvestor.
Grievance Officer Details: Name: Srikanth Meenakshi; Email: contact@primeinvestor.
Get access to fresh stocks and mutual funds recommendations.
